ZA983921B - A new process for the preparation of a pharmacologically active substance - Google Patents

A new process for the preparation of a pharmacologically active substance

Info

Publication number
ZA983921B
ZA983921B ZA983921A ZA983921A ZA983921B ZA 983921 B ZA983921 B ZA 983921B ZA 983921 A ZA983921 A ZA 983921A ZA 983921 A ZA983921 A ZA 983921A ZA 983921 B ZA983921 B ZA 983921B
Authority
ZA
South Africa
Prior art keywords
preparation
active substance
pharmacologically active
new process
new
Prior art date
Application number
ZA983921A
Other languages
English (en)
Inventor
Maria Bakonyi
Marianna Csatarinee Nagy
Leventene Molnar
Antal Gajary
Edit Alattyani
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA983921B publication Critical patent/ZA983921B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA983921A 1997-05-13 1998-05-08 A new process for the preparation of a pharmacologically active substance ZA983921B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700885A HU222283B1 (hu) 1997-05-13 1997-05-13 Eljárás tieno[3,2-c]piridin-származékok előállítására

Publications (1)

Publication Number Publication Date
ZA983921B true ZA983921B (en) 1998-11-09

Family

ID=90014236

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983921A ZA983921B (en) 1997-05-13 1998-05-08 A new process for the preparation of a pharmacologically active substance

Country Status (38)

Country Link
US (1) US6180793B1 (ru)
EP (1) EP0981529B1 (ru)
KR (1) KR100428238B1 (ru)
CN (1) CN1109036C (ru)
AR (1) AR014349A1 (ru)
AT (1) ATE212025T1 (ru)
AU (1) AU735702B2 (ru)
BR (1) BR9809112B1 (ru)
CA (1) CA2289623C (ru)
CO (1) CO4950564A1 (ru)
CZ (1) CZ292820B6 (ru)
DE (1) DE69803176T2 (ru)
DK (1) DK0981529T3 (ru)
DZ (1) DZ2487A1 (ru)
EE (1) EE03925B1 (ru)
EG (1) EG21973A (ru)
ES (1) ES2172141T3 (ru)
HK (1) HK1027350A1 (ru)
HR (1) HRP980240B1 (ru)
HU (1) HU222283B1 (ru)
ID (1) ID23018A (ru)
IL (1) IL132774A0 (ru)
IS (1) IS1883B (ru)
ME (1) ME01636B (ru)
MY (1) MY121299A (ru)
NO (1) NO325419B1 (ru)
NZ (1) NZ501577A (ru)
PL (1) PL194859B1 (ru)
PT (1) PT981529E (ru)
RS (1) RS49626B (ru)
RU (1) RU2172315C1 (ru)
SA (1) SA98190583B1 (ru)
SK (1) SK283700B6 (ru)
TR (1) TR199902783T2 (ru)
TW (1) TW552263B (ru)
UA (1) UA66359C2 (ru)
WO (1) WO1998051689A1 (ru)
ZA (1) ZA983921B (ru)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769313B1 (fr) * 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
HU226421B1 (en) 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
IN191030B (ru) * 2001-01-24 2003-09-13 Cadila Healthcare Ltd
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
ITMI20020933A1 (it) * 2002-05-03 2003-11-03 Danimite Dipharma S P A Procedimento per la sintesi di clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6812363B2 (en) * 2002-10-15 2004-11-02 Usv Limited Racemization of optically active 2-substituted phenyl glycine esters
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
US7872019B2 (en) 2003-03-12 2011-01-18 Cadila Healthcare Limited Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
WO2005063708A2 (en) 2003-11-03 2005-07-14 Cadila Healthcare Limited Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
KR100553398B1 (ko) 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
JP2007513889A (ja) * 2004-09-21 2007-05-31 テバ ファーマシューティカル インダストリーズ リミティド 結晶性クロピドグレル臭酸塩及びその調製方法
MX2007010267A (es) * 2005-02-24 2007-09-11 Teva Pharma Base de clopidogrel adecuada para formulacion farmaceutica y preparacion de ella.
KR100681512B1 (ko) 2005-03-08 2007-02-09 주식회사 한서켐 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법
KR101235117B1 (ko) 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
WO2007125544A2 (en) * 2006-04-27 2007-11-08 Ind-Swift Laboratories Limited Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate
KR20080055860A (ko) * 2006-08-03 2008-06-19 테바 파마슈티컬 인더스트리즈 리미티드 클로피도그렐 바이설페이트의 제조 방법
US8247558B2 (en) 2006-09-04 2012-08-21 Ranbaxy Laboratories Limited Process for the preparation of clopidogrel and its pharmaceutically acceptable salts
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
KR100990949B1 (ko) 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
US20110190502A1 (en) * 2008-10-24 2011-08-04 Sandoz Ag Process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN101544655B (zh) * 2009-05-05 2012-07-04 上海医药集团股份有限公司 噻吩并[3，2-c]吡啶衍生物的制备方法
CN101863899B (zh) * 2010-06-21 2013-03-20 常州制药厂有限公司 一种提高氯吡格雷樟脑磺酸盐拆分收率的方法
KR20170004282A (ko) 2015-07-02 2017-01-11 류종렬 수도 지지부가 구비된 쉐이크 핸드형 탁구 라켓
KR20170004283A (ko) 2015-07-02 2017-01-11 류종렬 그립부가 개선된 쉐이크 핸드형 탁구 라켓

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
NO995533D0 (no) 1999-11-12
UA66359C2 (ru) 2004-05-17
DZ2487A1 (fr) 2004-07-30
ES2172141T3 (es) 2002-09-16
BR9809112B1 (pt) 2010-10-05
KR20010012511A (ko) 2001-02-15
EE9900488A (et) 2000-06-15
CA2289623A1 (en) 1998-11-19
US6180793B1 (en) 2001-01-30
CN1255924A (zh) 2000-06-07
DE69803176D1 (de) 2002-02-21
EE03925B1 (et) 2002-12-16
TW552263B (en) 2003-09-11
DK0981529T3 (da) 2002-04-22
IS5244A (is) 1999-11-11
EP0981529B1 (en) 2002-01-16
ID23018A (id) 1999-12-30
CN1109036C (zh) 2003-05-21
JP4256478B2 (ja) 2009-04-22
SK151699A3 (en) 2000-07-11
CO4950564A1 (es) 2000-09-01
JP2001525819A (ja) 2001-12-11
NZ501577A (en) 2001-10-26
HK1027350A1 (en) 2001-01-12
EP0981529A1 (en) 2000-03-01
YU58799A (sh) 2002-06-19
HUP9700885A2 (hu) 1999-09-28
IS1883B (is) 2003-08-15
WO1998051689A1 (en) 1998-11-19
SA98190583B1 (ar) 2006-08-19
EG21973A (en) 2002-05-31
CZ292820B6 (cs) 2003-12-17
PL336693A1 (en) 2000-07-03
HUP9700885D0 (en) 1997-07-28
ATE212025T1 (de) 2002-02-15
KR100428238B1 (ko) 2004-04-30
PL194859B1 (pl) 2007-07-31
HU222283B1 (hu) 2003-05-28
AU735702B2 (en) 2001-07-12
DE69803176T2 (de) 2002-08-22
BR9809112A (pt) 2000-08-01
HUP9700885A3 (en) 2000-06-28
CA2289623C (en) 2007-01-30
HRP980240B1 (en) 2003-02-28
MY121299A (en) 2006-01-28
AU7444898A (en) 1998-12-08
RS49626B (sr) 2007-08-03
ME01636B (me) 2007-08-03
SK283700B6 (sk) 2003-12-02
AR014349A1 (es) 2001-02-28
HRP980240A2 (en) 1999-02-28
RU2172315C1 (ru) 2001-08-20
NO325419B1 (no) 2008-04-21
CZ393999A3 (cs) 2000-04-12
IL132774A0 (en) 2001-03-19
NO995533L (no) 1999-12-13
TR199902783T2 (xx) 2000-04-21
PT981529E (pt) 2002-06-28

Similar Documents

Publication Publication Date Title
HK1027350A1 (en) A new process for the preparation of a pharmacologically active substance
PL326353A1 (en) Pharmaceutically active quinozolinic compounds
HRP980590B1 (en) A process for the preparation of a pharmaceutical poduct
AU2080199A (en) New pharmaceutically active compounds
HK1028619A1 (en) Process for the preparation of a polyamide-polyurethane micro-blend
AU4174196A (en) Process for the preparation of a pharmacologically active chemical combination
GB9526511D0 (en) Pharmaceutically active compounds
IL131205A0 (en) Process for preparing pharmaceutical compounds
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
EG21226A (en) Process for preparing of new pharmaceutical compound
AU3840199A (en) Process for the preparation of a pharmaceutical intermediate
ZA9811285B (en) New pharmaceutically active compounds
IL121253A0 (en) A process for the preparation of para-fluorophenol
TJ218R3 (en) A method for the preparation of a substance having cholagogic activity
TJ213R3 (en) A method for the preparation of a substance having immunostimulate activity
GB9702447D0 (en) Pharmacologically active compound
GB9704275D0 (en) Pharmacologically active compound
GB9708183D0 (en) Pharmacologically active compound
GB9510468D0 (en) Pharmaceutically active compounds
GB9521231D0 (en) Pharmaceutically active compounds
GB9502229D0 (en) Pharmaceutically active compounds
GB9518486D0 (en) Pharmaceutically active compounds
GB9518039D0 (en) Pharmaceutically active compounds
GB9515884D0 (en) Pharmaceutically active compounds
GB9514396D0 (en) Pharmaceutically active compounds